Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform

Trial search

Filter Options
Public title		Scientific title	Subject ID
Registration Status		Registration number	Secondary ID
Applicant		Study leader	Year
Primary sponsor		Secondary sponsor	Source(s) of funding
Target disease		Target disease code	Study type
Study phase		Study design	Study execute time	From To
Recruiting status		Gender	Sign the informed consent
Countries of recruitment and research settings	Nation(Area)：Province：City： Institution：Level of the institution：
Intervention		Intervention code	Approved by ethic committee
Calculated Results after the Study Completed public access		Statistical results after completion of the test file upload
	More Options

5 trials have been registered

Historical versions	Registration number	Public title	Type	Registration time
Historical Versions	ChiCTR2100043538	Predicting fluid responsiveness in patients on veno-arterial extracorporeal membrane oxygenation by using heart-lung interaction mechanism The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital	Diagnostic test	2021/02/21
Historical Versions	ChiCTR2100043201	Serum C-peptide derivative parameters and risk assessment of chronic complications in type 2 diabetes mellitus The First Affiliated Hospital of Harbin Medical University	Observational	2021/02/08
Historical Versions	ChiCTR2100043168	Multicenter clinical study of flumatinib combined with chemotherapy in the treatment of adult patients (aged between 65 to 70 years) newly diagnosed with Ph+ALL Department of Hematology, The First Affiliated Hospital of Chongqing Medical University	Interventional	2021/02/07
Historical Versions	ChiCTR2100043153	PD-1 inhibitor combind with TACE as a adjavant therapy for high recurrent risk HCC: a open label, non randomized controlled study. Hepatobiliary Surgery Department,Shanghai Public Health Clinical Center	Interventional	2021/02/06
Historical Versions	ChiCTR1900027815	The second-line treatment of recurrent and metastatic cervical cancer with sintilimab combined pemetrexed regimen: a single-arm, single-center clinical trial Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Interventional	2019/11/29